-
Lupin's generic Clarinex gets FDA approval
SILVER SPRING, Md. The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for allergies, according to FDA records.
The drug is a generic version of Schering-Plough’s Clarinex.
Clarinex has annual sales of around $229 million, according to IMS Health data reported by several media in India, where Lupin is based.
-
BIO, GPhA and Sandoz testify at FDA biosimilars hearing
SILVER SPRING, Md. The main lobbies for the biotechnology and generic drug industries, and a leading manufacturer of generic drugs, testified Wednesday at a hearing sponsored by the Food and Drug Administration to collect public and industry input on the implementation of the regulatory approval pathway for follow-on biologics included in the healthcare-reform bill.